ERK signaling, which acts upstream of IEGs, is activated in LID [39, 40]; ERK1/2 phosphorylation was positively correlated with increased ΔFosB level and with the degree of dyskinesia in mice [26], whereas ERK inhibition reduced LID incidence and severity [27]. Here, MAPK3 is linked to drug-induced dyskinesia.